Please ensure Javascript is enabled for purposes of website accessibility

Are You Expecting This from McKesson?

By Seth Jayson – Updated Apr 10, 2017 at 7:28AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Checking expectations

McKesson (NYSE: MCK) is expected to report Q4 earnings on May 7. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict McKesson's revenues will increase 1.0% and EPS will grow 10.0%.

The average estimate for revenue is $32.01 billion. On the bottom line, the average EPS estimate is $2.30.

Revenue details
Last quarter, McKesson reported revenue of $31.19 billion. GAAP reported sales were 1.1% higher than the prior-year quarter's $30.84 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $1.41. GAAP EPS of $1.24 for Q3 were 3.3% higher than the prior-year quarter's $1.20 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 5.3%, 10 basis points better than the prior-year quarter. Operating margin was 1.7%, 10 basis points worse than the prior-year quarter. Net margin was 1.0%, much about the same as the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $123.73 billion. The average EPS estimate is $7.20.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 616 members out of 644 rating the stock outperform, and 28 members rating it underperform. Among 219 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 212 give McKesson a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $104.23.

Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends McKesson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.